Enzo Biochem Acquires Assay Designs | GenomeWeb

NEW YORK (GenomeWeb News) – Enzo Biochem said after the close of the market Thursday that it has acquired Assay designs for roughly $12.2 million, subject to post-closing price adjustments based on the private firm's working capital as of the closing date.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.